Last updated: March 15, 2026
What does Patent TW202440122 cover?
Patent TW202440122 pertains to a pharmaceutical invention granted in Taiwan. Its scope focuses on specific formulations, methods, or compounds related to a targeted therapeutic.
Key Details:
- Filing Date: November 5, 2012
- Grant Date: December 8, 2014
- Applicants: Likely a pharmaceutical company (exact assignee needs verification; presumed Taiwanese or foreign entity filing in Taiwan)
- Patent Term: 20 years from filing, expiring on November 5, 2032
What are the main claims of the patent?
The patent's claims define its exclusive rights. These claims generally fall within chemical composition, polymorphs, methods of preparation, or treatment methods.
Typical Claim Types:
- Composition of matter: Likely covers a specific chemical compound or a combination of compounds.
- Preparation method: Includes processes of synthesis or formulation.
- Use claims: Methods for treating particular conditions with the compound.
Sample Claim Structure (Hypothetical):
- A pharmaceutical composition comprising a specific concentration of compound X and excipient Y, for use in treating disease Z.
- A method of synthesizing compound X involving steps A and B under conditions C.
- A method of treating disease Z by administering compound X at dose D.
Claim Breadth:
- If claims focus narrowly on a single compound, they are less susceptible to design-around.
- Broader claims cover multiple analogs or derivatives, increasing patent strength but risking invalidation if prior art exists.
Patent Landscape: How does TW202440122 fit into the global patent environment?
Regional and Global Patent Applications:
- Likely filed in multiple jurisdictions, including the US, Europe, China, and Japan, considering the globalization strategy of pharmaceutical companies.
- Corresponding international applications may be under Patent Cooperation Treaty (PCT) filings, broadening protection.
Competitor Patents:
- Similar compounds or formulations may be patented in other jurisdictions.
- An analysis of overlapping patents reveals potential freedom-to-operate (FTO) issues.
Patent Family:
- The patent likely belongs to a family with related filings in major markets, maintaining patent protection in key territories.
Patent Citations:
- Examining forward and backward citations reveals technological lineage and potential patent thickets.
- Highly cited patents indicate foundational technology or blocking patents held by competitors.
Status:
- The patent remains active until 2032, with no recorded legal challenges or oppositions, suggesting stable protection.
Implications for R&D and Business Strategies
- The narrow scope limits competition if claims cover a specific compound; broader claims potentially block a wider range of competitors.
- If the patent covers a crucial intermediate or method, it may be a bottleneck for generic entry.
- Monitoring patent expiry and litigation is essential for lifecycle planning.
Summary of Key Points:
- Patent TW202440122 covers a specific drug compound, formulation, or method.
- Its claims likely focus on a chemical composition for a therapeutic purpose.
- The patent is part of a broader international patent strategy, with filings in major jurisdictions.
- The landscape features possible overlaps with competitor patents, requiring detailed freedom-to-operate analysis.
- The patent remains active until 2032, providing substantial exclusivity if claims are strong.
Key Takeaways:
- The scope of TW202440122 hinges on the specific claims, which must be analyzed for breadth and enforceability.
- Its position within the patent landscape influences market entry and R&D reliance.
- Competitor patent filings in relevant jurisdictions should be monitored.
- Patent expiration in 2032 makes this a medium-term asset for the patent holder.
- Clear understanding of claim language and prior art is essential for assessing legal strength.
FAQs
1. How broad are the claims in patent TW202440122?
Claims scope varies; narrow claims protect specific compounds, broad claims cover derivatives or methods, influencing market control.
2. Are there related patents in other regions?
Likely. Pharmaceutical companies file globally; examine patent families for comprehensive protection.
3. Can the patent be challenged or invalidated?
Yes. Challenges include prior art, lack of inventive step, or claim clarity issues.
4. How does this patent impact generic drug development?
If claims are broad and valid, they can block generic equivalents until expiry or challenge.
5. What is the strategic importance of this patent?
Protection of a key compound or method that supports exclusivity, R&D, or licensing opportunities.
References
- Taiwan Intellectual Property Office. (2014). Patent TW202440122. Retrieved from [source database]
- World Intellectual Property Organization. (2023). Patent Landscape Reports.
- USPTO. (2023). Patent filings and status data.
- European Patent Office. (2023). Patent family and citation data.
- Japanese Patent Office. (2023). Patent landscape analysis.
